Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database
about
Association of statin use with pathological tumor characteristics and prostate cancer recurrence after surgeryStatin Use in Prostate Cancer: An UpdateStatins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysisEffects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals.Suppression of interactions between prostate tumor cell-surface integrin and endothelial ICAM-1 by simvastatin inhibits micrometastasisExploiting the critical perioperative period to improve long-term cancer outcomes5-α reductase inhibitors and prostate cancer prevention: where do we turn now?Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumorsThe association between statin medication and progression after surgery for localized renal cell carcinoma.Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer.Simultaneous modulation of the intrinsic and extrinsic pathways by simvastatin in mediating prostate cancer cell apoptosisStatin use and the risk of recurrence after radical prostatectomy in a cohort of men with inherited and/or early-onset forms of prostate cancer.Inhibitory effect of dietary atorvastatin and celecoxib together with voluntary running wheel exercise on the progression of androgen-dependent LNCaP prostate tumors to androgen independenceStatin use and fatal prostate cancer: a matched case-control study.Statins and prostate cancer: role of cholesterol inhibition vs. prevention of small GTP-binding proteinsAssociation between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) studyStatin Use Reduces Prostate Cancer All-Cause Mortality: A Nationwide Population-Based Cohort StudyMetabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer.Association of fatty-acid synthase polymorphisms and expression with outcomes after radical prostatectomy.New players for advanced prostate cancer and the rationalisation of insulin-sensitising medicationTranscriptional profiling of breast cancer cells in response to mevinolin: Evidence of cell cycle arrest, DNA degradation and apoptosis.Influence of concurrent medications on outcomes of men with prostate cancer included in the TAX 327 study.The effect of statins on prostate cancer recurrence and mortality after definitive therapy: a systematic review and meta-analysisInfluence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone Acetate.Role of HMG-CoA reductase inhibitors with curative radiotherapy in men with prostate cancer.Combination of Lipitor and Celebrex inhibits prostate cancer VCaP cells in vitro and in vivo.Does Statin or ASA Affect Survival When Prostate Cancer Is Treated with External Beam Radiation Therapy?Statin use in relation to prostate cancer outcomes in a population-based patient cohort study.Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib.Effects of 14 frequently used drugs on prostate-specific antigen expression in prostate cancer LNCaP cells.Dyslipidemia, statins and prostate cancer.Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a meta-analysis of eight cohort studies.Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature.Synergism between metformin and statins in modifying the risk of biochemical recurrence following radical prostatectomy in men with diabetes.Hypercholesterolemia Is Associated with a Shorter Time to Castration-Resistant Prostate Cancer in Patients Who Have Undergone Androgen Deprivation TherapyThe Prognostic Effect of Statin Use on Urologic Cancers: An Updated Meta-Analysis of 35 Observational Studies.CYP27A1 Loss Dysregulates Cholesterol Homeostasis in Prostate Cancer.Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statinsStatin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer.
P2860
Q24614649-CEC462D1-5E22-40A0-9EB8-20DD346F8919Q26738631-9F2FE264-5140-4BE2-AB5A-141C830C03F3Q27000727-04DA98C1-0601-4F75-92D5-C8A6AB439637Q30241078-C86FEE37-02F8-4F22-B36E-C22D30EFDF8CQ33684159-9FFB084F-5511-440F-8F91-DDB778198965Q33871661-BF6E0ABE-3A0F-47B9-98B7-092907A10689Q34020127-F5B5FF97-663F-4C85-8726-3D0C3D043FEAQ34141720-043F3F67-DA53-45B3-8003-AE17C1F973CBQ34206127-FD4C9675-0E9A-4186-96F9-7EE893CA247EQ34289164-B4E99D70-642D-4CEE-9679-6470D40D80DDQ34413892-1115321E-6FE2-444F-81A4-C62FB9DF87E7Q34502662-EBE8C5A8-AAAC-43A6-AB3C-FBBD5C696092Q35030507-3E7C9C62-CF08-41E3-A059-96E726F358D3Q35038889-AC79BBA0-8AB6-4E27-A1A5-EFFEA028A074Q35264079-7681C324-2357-4B81-981E-1D810C05AD52Q35897294-49F969BE-E36D-4B00-A2EF-8234895B9C79Q36044730-41D87B6E-A771-4868-B207-7FEAA413ED03Q36195699-A4FCB0D3-36C1-47F5-9D3A-524A274780D3Q36260667-BEB46E68-ADAB-487A-A493-A898F1232501Q36570819-C1D4D323-0BC4-4233-9A79-C6677B1691C9Q36734036-ABB3F23F-AB94-45B7-B8BF-A1385E486416Q36734181-EDA50DFD-DD85-48B4-92E9-307BBF54CEC4Q36833801-DE814B18-89FD-4C99-873F-60C42F3C98E0Q37072692-FE901211-5DE6-4766-B422-4A27AD52452FQ37226646-2A155F2F-617C-4E2B-AE94-2B9BBD56C2CBQ37283766-50C530E4-D8B0-4383-BE94-BD05D214FDFFQ37596358-B64877DA-91E0-4B1D-9A2E-BBEC18F3D10FQ37650468-200293EE-D98B-4A54-9CB8-66C5E47136FCQ37667939-9C814779-74C4-4ABF-8AD2-A95559D05FB2Q37694029-17225614-3DD4-4DD8-854F-835809760260Q37720026-3AF9950A-4FDD-4F9F-B51F-57BF2BF9BA74Q38030598-A1A1AE3B-A9CD-476E-AD0C-AA6E53914F1FQ38047044-88A0A997-C1CC-4780-8F06-F8ED597B62D7Q38226775-FF797AE3-BABC-47A2-BB22-69BB2A3EEA85Q38268809-902E254C-6481-4F95-A3EB-96D0F0EF280EQ38414609-932F0E69-8064-4BC0-9661-F8E9735F006DQ38584232-6ACB0985-8CD3-4CC7-9C6B-9E4CA8CC624BQ38719045-7936F5CB-1923-43D2-B25B-5B95D6CC4C43Q38846866-878580CA-F1F4-4939-B01F-9376DB71265AQ38852322-1F74AECF-8077-45AE-8AFE-FEA75A549C44
P2860
Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Statin medication use and the ...... cer Hospital (SEARCH) Database
@ast
Statin medication use and the ...... cer Hospital (SEARCH) Database
@en
type
label
Statin medication use and the ...... cer Hospital (SEARCH) Database
@ast
Statin medication use and the ...... cer Hospital (SEARCH) Database
@en
prefLabel
Statin medication use and the ...... cer Hospital (SEARCH) Database
@ast
Statin medication use and the ...... cer Hospital (SEARCH) Database
@en
P2093
P2860
P356
P1433
P1476
Statin medication use and the ...... cer Hospital (SEARCH) Database
@en
P2093
Christopher J Kane
Christopher L Amling
Elizabeth A Platz
Joseph C Presti
Lionel L Banez
Martha K Terris
Robert J Hamilton
Stephen J Freedland
William J Aronson
P2860
P304
P356
10.1002/CNCR.25308
P407
P577
2010-07-01T00:00:00Z